Overview
- 60 inspections across 60 sites are on record.
- 208 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-02-10.
At a glance
Inspections
60
Sites
60
Observations
208
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AGC Biologics, Inc. | 10 Feb 2023 | Human Drugs | On file |
| SMS Pharmaceuticals Limited | 5 Mar 2020 | Human Drugs | |
| VKT Pharma Private Limited | 28 Feb 2020 | Human Drugs | View 483 → |
| Mayon'S Pharmaceuticals Pvt Ltd | 20 Feb 2020 | Human Drugs | View 483 → |
| Airgas USA, LLC | 9 Oct 2019 | Human Drugs |
Sites inspected
AGC Biologics, Inc.Bothell, United States1 insp.
SMS Pharmaceuticals LimitedHyderabad, India1 insp.
VKT Pharma Private LimitedSrikakulam, India1 insp.
Mayon'S Pharmaceuticals Pvt LtdNagpur, India1 insp.
Airgas USA, LLCLos Angeles, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ian J Thomson4 shared
Peter S Kessler2 shared
Anita Narula2 shared
Kenneth O Gee2 shared
Cynthia L Gorveatt2 shared
Christopher S Genther2 shared
Jinkee M Vila Binayug2 shared
Charles Y Kuo1 shared
Yuan-Chia Kuo1 shared
Michael Araneta1 shared
Full investigator report
Get the verbatim findings behind Andrew K Haack's 208 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site